Careers

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2023 Healthcare Supply Chain Leadership Summit
    • 2024 National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • HSCA Connect
  • Events
    • 2023 Healthcare Supply Chain Leadership Summit
    • 2024 National Pharmacy Forum
    • Past Events
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News

HSCA Comments to EPA on Proposal to Reduce Ethylene Oxide Emissions (EtO) from Commercial Sterilization Facilities and Proposed Interim Decision and Draft Risk Assessment Addendum for Ethylene Oxide

June 28, 2023 by Grace Crozier Federal Comments 0 comments

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Environmental Protection Agency (EPA) on ethylene oxide (EtO).

Please find comments regarding the proposed amendments to the National Emission Standards for Hazardous Air Pollutants (NESHAP) for the Commercial Sterilization Facilities source category here.

Please find comments regarding the proposed interim registration review decision and draft risk assessment addendum for ethylene oxide (EtO) here.

Prev
Next

Related Posts

HSCA Comments on FDA Draft Guidance for Drug Supply Chain Security Act (DSCSA) Standards
November 9, 2022

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...

Learn more
HSCA Comments on FDA “Risk Management Plans to Mitigate the Potential for Drug Shortages” Draft Guidance
August 22, 2022

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...

Learn more
HSCA Response to FDA Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Draft Guidance
June 5, 2023

On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...

Learn more
HSCA Comments to EPA on Proposal to Reduce Ethylene Oxide Emissions (EtO) from Commercial Sterilization Facilities and Proposed Interim Decision and Draft Risk Assessment Addendum for Ethylene Oxide
June 28, 2023

On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...

Learn more

Our Office

Healthcare Supply Chain Association
1341 G Street NW Suite 600
Washington, DC 20005

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • HSCA NAMES CHILDREN’S HOSPITAL ASSOCIATION VICE PRESIDENT OF PHARMACY TERRI LYLE WILSON TO BOARD OF DIRECTORS
    September 20, 2023
  • HSCA Response to Congressional Drug Shortages Request for Information (RFI)
    July 7, 2023